Tempest Therapeutics Inc.
(TPST)
undefined
undefined%
At close: undefined
0.95
0.27%
Pre-market Jan 07, 2025, 04:26 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -29.49M | -35.71M | -28.30M | -19.21M | -44.57M | -27.19M | -84.58M | -82.26M | -73.22M | -49.52M | -29.04M | -13.51M |
| Depreciation & Amortization | 381.00K | 638.00K | 374.00K | 339.00K | 1.05M | 32.00K | 28.00K | 2.24M | 1.29M | 450.00K | 231.00K | 93.00K |
| Stock-Based Compensation | 2.55M | 1.56M | 1.10M | 453.00K | 310.00K | 1.43M | 6.89M | 9.21M | 19.34M | 12.41M | 5.09M | 1.38M |
| Other Working Capital | -2.41M | 867.00K | -404.00K | -497.00K | -1.58M | 716.00K | -392.00K | 5.75M | -361.00K | 10.08M | 10.14M | -599.00K |
| Other Non-Cash Items | 1.88M | 1.57M | 1.48M | 470.00K | 6.92M | 2.22M | 67.56M | 19.36M | 24.92M | -6.33M | -3.80M | 879.00K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | -2.57M | n/a | n/a | n/a | n/a | n/a | n/a | -599.00K |
| Change in Working Capital | -2.68M | 868.00K | -613.00K | -1.07M | -2.05M | 1.04M | -1.84M | 4.58M | -532.00K | 12.40M | 9.42M | 599.00K |
| Operating Cash Flow | -27.36M | -31.07M | -25.96M | -19.02M | -41.22M | -23.65M | -20.34M | -61.73M | -50.29M | -30.59M | -18.09M | -11.16M |
| Capital Expenditures | -170.00K | -562.00K | -135.00K | -50.00K | -397.00K | -36.00K | -4.00K | -2.59M | -5.23M | -2.80M | -719.00K | -849.00K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | -1.33M | 462.00K | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | -68.86M | -84.42M | -96.72M | -57.60M | -15.97M | -16.70M |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | 4.38M | 2.49M | 87.79M | 95.10M | 64.34M | 29.23M | 5.67M | n/a |
| Other Investing Acitivies | n/a | n/a | 38.00K | 44.00K | n/a | 476.00K | -1.45M | -1.55M | -681.00K | -1.61M | 5.00K | -93.00K |
| Investing Cash Flow | -170.00K | -562.00K | -97.00K | -6.00K | 3.99M | 1.12M | 458.00K | 8.10M | -38.29M | -32.79M | -11.02M | -17.64M |
| Debt Repayment | n/a | -4.74M | 15.00M | n/a | -202.00K | 6.48M | -4.46M | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | 7.28M | 10.64M | 34.60M | 27.14M | 33.32M | n/a | n/a | n/a | n/a | n/a | n/a |
| Financial Cash Flow | 35.60M | 11.40M | 59.06M | 34.60M | 26.94M | 78.55M | -4.46M | 54.15M | 125.39M | 51.71M | 32.41M | 39.03M |
| Net Cash Flow | 8.07M | -20.23M | 33.01M | 15.58M | -9.82M | 55.71M | -26.31M | 706.00K | 37.01M | -11.66M | 3.30M | 10.23M |
| Free Cash Flow | -27.53M | -31.63M | -26.09M | -19.07M | -41.62M | -23.68M | -20.34M | -64.32M | -55.52M | -33.39M | -18.81M | -12.01M |